Iberia Pharmaceuticals India Limited

Iberia Pharmaceuticals India Limited - trading in New Delhi, Delhi, India. FY 2026 financials and compliance.
CIN U24232DL2013PLC250040 Incorporated 30 March 2013 ROC Delhi HQ New Delhi, Delhi, India
Active Public Limited Company trading
Data last updated
Revenue · FY 2023
₹67.39 Cr
▲ 54.00% YoY
EBITDA · FY 2023
Locked
In full report
Net profit · FY 2023
Locked
In full report
Authorised capital
₹30 Cr
Registered with MCA
Paid-up capital
₹17.66 Lakh
Issued & subscribed
Open charges
₹10.25 Cr
Secured borrowings
Company age
13 yrs
Est. 2013
Employees · EPFO
140
Latest available

About Iberia Pharmaceuticals India Limited

Data last updated: 06 January 2026

Iberia Pharmaceuticals India Limited is a public limited company based in New Delhi, Delhi, India. It specialises in wholesale trading and distribution, a part of the broader trading and commerce sector. Incorporated on 30 March 2013, the company has been in operation for over 13 years.

Registered with ROC Delhi under CIN U24232DL2013PLC250040.

Capital: an authorised share capital of ₹30 Cr and a paid-up capital of ₹17.66 Lakh. Formerly known as Satnam Medical Agencies Private Limited and Iberia Pharmaceuticals India Limited. It is led by directors including Rishab Jain and Nitin Jain.

Last AGM: 30 September 2024. Financial statements filed for year ended 31 March 2024. Office: Property No. 4 Block – C First Floor, Sector – 8 Dwarka, New Delhi, Delhi, India – 110077.

As per the financials filed for FY 2023, the company reported a revenue of ₹67.39 Cr, a growth of 54% compared to the previous year.

The company has a workforce of approximately 140 employees as per the latest available data.

As per MCA filings, the company has open charges of ₹10.25 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Iberia Pharmaceuticals India Limited
CIN U24232DL2013PLC250040
Registration Number 250040
Incorporation Date 30 March 2013
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    Property No. 4 Block – C First Floor, Sector – 8 Dwarka, New Delhi, Delhi, India – 110077
  • Industry
    Trading, Wholesale, Other Wholesale
Company report
Iberia Pharmaceuticals India Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Iberia Pharmaceuticals India Limited report

Financials, compliance, directors, charges, ownership and filings for Iberia Pharmaceuticals India Limited in one report.

10-year financials Directors & ownership Charges & compliance

Name History of Iberia Pharmaceuticals India Limited

Iberia Pharmaceuticals India Limited has undergone 2 name changes throughout its history. The company was previously known as Satnam Medical Agencies Private Limited, and Iberia Pharmaceuticals India Limited. The current legal name is Iberia Pharmaceuticals India Limited, reflecting the company's evolution and rebranding over time.

Company Name Status
Iberia Pharmaceuticals India Limited Current
Satnam Medical Agencies Private Limited Previous

CIN History of Iberia Pharmaceuticals India Limited

Iberia Pharmaceuticals India Limited has one previous CIN (Corporate Identification Number): U24232DL2013PTC250040. The current CIN is U24232DL2013PLC250040, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
U24232DL2013PLC250040 Current
U24232DL2013PTC250040 Previous

Business Activity of Iberia Pharmaceuticals India Limited

Iberia Pharmaceuticals India Limited is engaged in the principal business activity of trade, with detailed activities including wholesale trading.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
G Trade G1 Wholesale Trading Locked
Premium access

Business activity turnover details for Iberia Pharmaceuticals India Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Iberia Pharmaceuticals India Limited

Iberia Pharmaceuticals India Limited is audited by KRA & Co. for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
KRA & Co. Locked Locked Locked
Premium access

Complete auditor history for Iberia Pharmaceuticals India Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Iberia Pharmaceuticals India Limited

Iberia Pharmaceuticals India Limited is currently managed by 6 directors, with 4 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Rishab Jain Whole-Time Director 02 May 2021 5 Years 2 Months Current
Nitin Jain Managing Director 30 Mar 2013 13 Years 3 Months Current
Harmeet Kaur Director 01 Mar 2025 1 Years 4 Months Current
Atul Bhola Director 01 Mar 2025 1 Years 4 Months Current
Aditya Rungta Director 01 Mar 2025 1 Years 4 Months Current
Saurav Ojha Whole-Time Director 30 Sep 2023 2 Years 9 Months Current

Financials of Iberia Pharmaceuticals India Limited FY 2024 filings available

Iberia Pharmaceuticals India Limited reported revenue of ₹67.39 Cr (up 54.00% YoY) for FY 2023.

Revenue · FY 2023
₹67.39 Cr ▲ 54.00%
Premium access

Ten-year financial statements for Iberia Pharmaceuticals India Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Iberia Pharmaceuticals India Limited

Premium access

Shareholding and ownership data for Iberia Pharmaceuticals India Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Iberia Pharmaceuticals India Limited

Open charges
₹10.25 Cr
Satisfied charges
₹0
Breakdown by lending institutions
Others₹10.00 Cr
Hdfc Bank Limited₹0.25 Cr
Latest charge details
DateLenderAmountStatus
27 Dec 2023 Others ₹10 Cr Open
27 Dec 2023 Hdfc Bank Limited ₹25.09 Lakh Open

Total charge records: 2 View all charges

Employees and EPFO Compliance at Iberia Pharmaceuticals India Limited

View historical data on people associated with Iberia Pharmaceuticals India Limited, including employment history and EPFO contributions.

Premium access

Employee and EPFO history for Iberia Pharmaceuticals India Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Iberia Pharmaceuticals India Limited

Premium access

GST registrations and filing compliance for Iberia Pharmaceuticals India Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Iberia Pharmaceuticals India Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Iberia Pharmaceuticals India Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Iberia Pharmaceuticals India Limited

Premium access

MSME payment history for Iberia Pharmaceuticals India Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Iberia Pharmaceuticals India Limited

Premium access

Corporate group structure for Iberia Pharmaceuticals India Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Iberia Pharmaceuticals India Limited

Premium access

MCA filings and documents for Iberia Pharmaceuticals India Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Iberia Pharmaceuticals India Limited

Directors
15 Oct 2025
Shripati Sharma was appointed as a Cfo on 15 Oct 2025 & has been associated with this company since 9 months 14 days.
Charges
06 Aug 2025
A charge with Others of Rs. 10.00 Cr registered on 27 Dec 2023 with Charge ID 100850475 was modified on 06 Aug 2025.
Directors
01 Apr 2025
Deepanshu was appointed as a Cfo on 01 Apr 2025 & has been associated with this company since 1 year 3 months.
Directors
01 Mar 2025
Harmeet Kaur was appointed as a Director on 01 Mar 2025 & has been associated with this company since 1 year 4 months.
Directors
01 Mar 2025
Atul Bhola was appointed as a Director on 01 Mar 2025 & has been associated with this company since 1 year 4 months.
Directors
01 Mar 2025
Aditya Rungta was appointed as a Director on 01 Mar 2025 & has been associated with this company since 1 year 4 months.

Frequently Asked Questions about Iberia Pharmaceuticals India Limited

Iberia Pharmaceuticals India Limited is an active public limited company in the trading sector based in New Delhi, Delhi, India. It was incorporated on 30 March 2013 (13+ years old) and is registered under CIN U24232DL2013PLC250040. The company has 140 employees.

Iberia Pharmaceuticals India Limited reported revenue of ₹67.39 Cr for FY 2023 (up 54.00% YoY).

The current directors of Iberia Pharmaceuticals India Limited are:

The primary industry of Iberia Pharmaceuticals India Limited is trading. The company specifically operates in wholesale. The company is currently active in this sector.

Iberia Pharmaceuticals India Limited can be reached at the registered office: Property No. 4 Block – C First Floor, Sector – 8 Dwarka, New Delhi, Delhi, India – 110077.

The authorised capital is ₹30 Cr, and the paid-up capital is ₹17.66 Lakh.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available